| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6d486b356f6aa1086e3c95fc90e55bc0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6cfafd44eaf0333511eb87793ad5b4f1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42db24cbf05c09bf1a7b699f56a9e5c2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7fbce31c732760bce77f50de1020a5ce
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e8b75bc75642354282da437947a4b573 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T436-25375
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S436-825
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S435-962 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56977
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N1-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39525
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-543 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-543
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 |
| filingDate |
2006-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f3f84a16633dad348c438e597ffa2d7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_71b1d3067b1c344eaa5fdf60252c4d52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7f7393ba798f9a3eec817f946f36019d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_52d23456bb9c7de3952ff5ab3b1ec2e1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c6b23bb75671b41465c6b7f0c5b35fff |
| publicationDate |
2007-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2007141050-A1 |
| titleOfInvention |
Methods of depleting antibodies directed towards major histocompatibility complex |
| abstract |
The invention provides a method of depleting anti-MHC antibodies in a sample comprising contacting said sample with one or more recombinant MHC molecules or functionally equivalent variants, derivatives or fragments thereof and removing at least the recombinant MHC molecules to which antibodies to said recombinant MHC molecules contained within the sample have bound. This method allows the depletion of one or more specific MHC particularly HLA allele antibodies from a sample. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8609436-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003017447-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008057521-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008303576-A1 |
| priorityDate |
2000-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |